Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Zach, M; Tmava-Berisha, A; Schatzl, S; Lehner, M; Vila, G; Amrein, K.
The HypAus study. First results of an Austrian multicentric observational study on chronic hypoparathyroidism
AUST J CLIN ENDOCR M. 2018; 11(2): 45-50.
Doi: 10.1007/s41969-018-0030-y
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Amrein Karin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hypoparathyroidism represents the last endocrine disorder that is not treated by the replacement of the missing hormone. The disease occurs mostly postoperatively and often manifests itself through hypocalcemia, though it can also present a wide spectrum of symptoms. Many patients suffer from an impaired quality of life. The current standard treatment is focused on controlling symptoms by oral administration of calcium and active and native vitamin D. Recent studies have suggested positive effects of parathormone replacement therapy, but due to its high cost it is currently not often used in clinical practice. In the course of the HypAus-Study, patients with chronic hypoparathyroidism have been evaluated regarding their etiology, symptoms, therapy and quality of life. In addition, some subjects have undergone neurocognitive testing. Preliminary results indicate a reduced quality of life and a tendency towards cognitive impairment.
- Find related publications in this database (Keywords)
- Hypoparathyroidism
- Complications, postoperative
- Hypocalcemia
- Hyperphosphatemia
- Quality of life